|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.20 EUR | -1.98% |
|
-4.67% | +0.68% |
| 12-04 | BioMérieux Launches Two Dedicated Equine Tests |  |
| 11-10 | UBS Maintains Buy Rating on BioMérieux, Confirms Price Target | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOMÉRIEUX | Diagnostic & Testing Substances | -1.98% | -4.67% | +0.68% | +7.09% | -10.86% | 14.64B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- BIM Stock
- Charts bioMérieux
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition